Iconovo (ICO) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.057x

Based on the latest financial reports, Iconovo (ICO) has a cash flow conversion efficiency ratio of -0.057x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-8.48 Million ≈ $-913.01K USD) by net assets (Skr149.29 Million ≈ $16.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ICO stock market capitalisation for the company's overall valuation and market capitalisation.

Iconovo - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Iconovo's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Iconovo Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Iconovo ranked by their cash flow conversion efficiency. Explore cash flow quality index of Iconovo to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Indbank Merchant Banking Services Limited
NSE:INDBANK
-0.032x
Investcorp Credit Management BDC Inc
NASDAQ:ICMB
0.205x
Golden Arrow Resources Corp
V:GRG
-0.208x
AVI Global Trust PLC
LSE:AGT
0.006x
City Chic Collective Ltd
AU:CCX
0.048x
Northeast Electric Development Company Limited
F:NE4H
0.009x
Mahube Infrastructure Ltd
JSE:MHB
0.009x
Kohinoor Foods Limited
NSE:KOHINOOR
-1.314x

Annual Cash Flow Conversion Efficiency for Iconovo (2016–2025)

The table below shows the annual cash flow conversion efficiency of Iconovo from 2016 to 2025. View Iconovo (ICO) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr117.92 Million
≈ $12.69 Million
Skr-31.87 Million
≈ $-3.43 Million
-0.270x -42.31%
2024-12-31 Skr129.21 Million
≈ $13.91 Million
Skr-24.54 Million
≈ $-2.64 Million
-0.190x +44.15%
2023-12-31 Skr113.53 Million
≈ $12.22 Million
Skr-38.60 Million
≈ $-4.15 Million
-0.340x +30.53%
2022-12-31 Skr89.29 Million
≈ $9.61 Million
Skr-43.70 Million
≈ $-4.70 Million
-0.489x -509.02%
2021-12-31 Skr137.03 Million
≈ $14.75 Million
Skr-11.01 Million
≈ $-1.19 Million
-0.080x +53.31%
2020-12-31 Skr92.73 Million
≈ $9.98 Million
Skr-15.96 Million
≈ $-1.72 Million
-0.172x -54.97%
2019-12-31 Skr108.79 Million
≈ $11.71 Million
Skr-12.08 Million
≈ $-1.30 Million
-0.111x -599.12%
2018-12-31 Skr63.99 Million
≈ $6.89 Million
Skr-1.02 Million
≈ $-109.38K
-0.016x +86.88%
2017-12-31 Skr31.52 Million
≈ $3.39 Million
Skr-3.82 Million
≈ $-410.77K
-0.121x -117.56%
2016-12-31 Skr8.73 Million
≈ $939.49K
Skr6.02 Million
≈ $647.74K
0.689x --

About Iconovo

ST:ICO Sweden Medical Devices
Market Cap
$12.26 Million
Skr113.96 Million SEK
Market Cap Rank
#26622 Global
#561 in Sweden
Share Price
Skr1.19
Change (1 day)
-0.42%
52-Week Range
Skr0.93 - Skr2.39
All Time High
Skr95.00
About

Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreeme… Read more